The Future of Longevity: AI, Epigenetics & Deep Space

Written By Adam Cowen

PanOmyx Cofounder Dr. Darrol Baker, examines advancements in longevity science, AI-driven healthcare, and space research. This overview highlights how epigenetic reprogramming, AI-powered bioinformatics, and multi-omics integration are enhancing our understanding of aging, disease, and human lifespan.

In particular:

·       Epigenetic reprogramming & telomere reversal—Investigating the potential to extend human life expectancy

·       AI & multi-omics—Facilitating drug discovery, disease modelling, and personalized healthcare

·       Longevity & deep space—Studying the effects of space travel on aging and telomere degradation

·       Generative AI in medicine—Reducing research time from 16 hours per gene to 1.5 hours

·       FAIR data & AI-driven clinical insights—Optimising patient screening, treatment, and monitoring

With AI transforming drug development and clinical decision-making, longevity science is progressing rapidly. From biological age reversal to space-based health innovations, advancements in human longevity are steadily approaching.

For more information on the role AI can play in the quest for longevity contact PanOmyx and let us explain.

Adam Cowen
Previous

Bridging the Gap Between Business and Science for Sustainable Success